148 related articles for article (PubMed ID: 15699431)
1. LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples.
Gomes-Solecki MJ; Savitt AG; Rowehl R; Glass JD; Bliska JB; Dattwyler RJ
Clin Diagn Lab Immunol; 2005 Feb; 12(2):339-46. PubMed ID: 15699431
[TBL] [Abstract][Full Text] [Related]
2. Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV.
Ivanov MI; Hill J; Bliska JB
Clin Vaccine Immunol; 2014 May; 21(5):667-73. PubMed ID: 24599533
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.
Miller NC; Quenee LE; Elli D; Ciletti NA; Schneewind O
Infect Immun; 2012 Apr; 80(4):1572-82. PubMed ID: 22252870
[TBL] [Abstract][Full Text] [Related]
5. Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague.
Eisele NA; Anderson DM
Clin Vaccine Immunol; 2009 Dec; 16(12):1720-7. PubMed ID: 19828767
[TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
[TBL] [Abstract][Full Text] [Related]
7. Glutathionylation of
Mitchell A; Tam C; Elli D; Charlton T; Osei-Owusu P; Fazlollahi F; Faull KF; Schneewind O
mBio; 2017 May; 8(3):. PubMed ID: 28512097
[TBL] [Abstract][Full Text] [Related]
8. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.
Philipovskiy AV; Cowan C; Wulff-Strobel CR; Burnett SH; Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
Infect Immun; 2005 Mar; 73(3):1532-42. PubMed ID: 15731051
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
Wang S; Goguen JD; Li F; Lu S
Vaccine; 2011 Sep; 29(39):6802-9. PubMed ID: 21199697
[TBL] [Abstract][Full Text] [Related]
10. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.
Noel BL; Lilo S; Capurso D; Hill J; Bliska JB
Clin Vaccine Immunol; 2009 Oct; 16(10):1457-66. PubMed ID: 19710295
[TBL] [Abstract][Full Text] [Related]
11. Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestis.
Hau D; Wade B; Lovejoy C; Pandit SG; Reed DE; DeMers HL; Green HR; Hannah EE; McLarty ME; Creek CJ; Chokapirat C; Arias-Umana J; Cecchini GF; Nualnoi T; Gates-Hollingsworth MA; Thorkildson PN; Pflughoeft KJ; AuCoin DP
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010287. PubMed ID: 35320275
[TBL] [Abstract][Full Text] [Related]
12. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
[TBL] [Abstract][Full Text] [Related]
13. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis.
Reithmeier-Rost D; Hill J; Elvin SJ; Williamson D; Dittmann S; Schmid A; Wilharm G; Sing A
Microbes Infect; 2007 Jul; 9(8):997-1002. PubMed ID: 17556003
[TBL] [Abstract][Full Text] [Related]
14. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.
Do Y; Koh H; Park CG; Dudziak D; Seo P; Mehandru S; Choi JH; Cheong C; Park S; Perlin DS; Powell BS; Steinman RM
Eur J Immunol; 2010 Oct; 40(10):2791-6. PubMed ID: 20812236
[TBL] [Abstract][Full Text] [Related]
15. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.
Cowan C; Philipovskiy AV; Wulff-Strobel CR; Ye Z; Straley SC
Infect Immun; 2005 Sep; 73(9):6127-37. PubMed ID: 16113334
[TBL] [Abstract][Full Text] [Related]
16. N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection.
Hill J; Leary S; Smither S; Best A; Pettersson J; Forsberg A; Lingard B; Lipka A; Brown KA; Williamson ED; Titball RW
Vaccine; 2009 Nov; 27(50):7073-9. PubMed ID: 19786138
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in the
Daniel C; Dewitte A; Poiret S; Marceau M; Simonet M; Marceau L; Descombes G; Boutillier D; Bennaceur N; Bontemps-Gallo S; Lemaître N; Sebbane F
Front Immunol; 2019; 10():1830. PubMed ID: 31428104
[TBL] [Abstract][Full Text] [Related]
18. Quantification of low abundance Yersinia pestis markers in dried blood spots by immuno-capture and quantitative high-resolution targeted mass spectrometry.
Rifflet A; Filali S; Chenau J; Simon S; Fenaille F; Junot C; Carniel E; Becher F
Eur J Mass Spectrom (Chichester); 2019 Jun; 25(3):268-277. PubMed ID: 31096787
[TBL] [Abstract][Full Text] [Related]
19. Development of a double-antibody sandwich ELISA for sensitive detection of Yersinia pestis.
Choi SY; Rhie GE; Jeon JH
Microbiol Immunol; 2020 Jan; 64(1):72-75. PubMed ID: 31621104
[TBL] [Abstract][Full Text] [Related]
20. Fast and simple detection of Yersinia pestis applicable to field investigation of plague foci.
Simon S; Demeure C; Lamourette P; Filali S; Plaisance M; Créminon C; Volland H; Carniel E
PLoS One; 2013; 8(1):e54947. PubMed ID: 23383008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
